Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy
Alberto Martini(The University of Texas MD Anderson Cancer Center), Marco Moschini(Vita-Salute San Raffaele University), Luca Afferi(Universitat Autònoma de Barcelona), Alberto Briganti(University College London Hospitals NHS Foundation Trust), Renzo Colombo(University of Insubria), Giuseppe Simone(Istituti di Ricovero e Cura a Carattere Scientifico), Ottavio De Cobelli(University of Milan), Andrea Gallina(San Raffaele University of Rome), Francesco Montorsi(Vita-Salute San Raffaele University), Mario Álvarez‐Maestro(Hospital Universitario La Paz), Matteo Soligo(Mayo Clinic), R. Jeffrey Karnes(Mayo Clinic), Armando Stabile(Royal Free London NHS Foundation Trust), Agostino Mattei(Luzerner Kantonsspital), Shahrokh F. Shariat(Universitätszahnklinik Wien), Ettore Di Trapani(European Institute of Oncology), Claudio Simeone(University of Brescia), Chiara Lonati(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Julianne G. Schultz(National Institutes of Health), Évanguelos Xylinas(NewYork–Presbyterian Hospital), Stefania Zamboni(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Giorgio Gandaglia(Vita-Salute San Raffaele University)
Cited by 22
Related Papers
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)
|World Journal of Urology|2016|471
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Epidemiology, Screening, and Prevention of Bladder Cancer
|European Urology Oncology|2022|361